LLY - ELI LILLY & Co
Close
777.265
1.655 0.213%
Share volume: 46,506
Last Updated: Thu 02 Jan 2025 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.50%
PREVIOUS CLOSE
CHG
CHG%
$775.61
1.66
0.21%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-04-27 | 2023-08-08 | 2023-11-02 | 2024-02-21 | 2024-04-30 | |
| Total revenue | 6.960 B | 8.312 B | 9.499 B | 9.353 B | 8.768 B | |
| Cost of revenue | 1.627 B | 1.807 B | 1.860 B | 1.788 B | 1.674 B | |
| Gross profit | 5.333 B | 6.505 B | 7.639 B | 7.565 B | 7.095 B | |
| 21.96% | 17.43% | -0.96% | -6.22% | |||
| Operating expenses | 3.734 B | 4.282 B | 4.213 B | 4.487 B | 4.475 B | |
| Selling general and admin | 1.749 B | 1.925 B | 1.804 B | 1.925 B | 1.952 B | |
| Research and development | 1.985 B | 2.357 B | 2.409 B | 2.563 B | 2.523 B | |
| Total expenses | 5.361 B | 6.089 B | 6.073 B | 6.275 B | 6.149 B | |
| 13.59% | -0.27% | 3.33% | -2.02% | |||
| Operating income | 1.599 B | 2.223 B | 3.426 B | 3.078 B | 2.620 B | |
| Ebit | 1.599 B | 2.223 B | 3.426 B | 3.078 B | 2.620 B | |
| Pretax income | 1.530 B | 2.089 B | 427.200 M | 2.509 B | 2.536 B | |
| 36.56% | -79.55% | 487.27% | 1.09% | |||
| Income tax | 184.800 M | 325.700 M | 484.600 M | 319.100 M | 293.200 M | |
| Net income basic | 1.345 B | 1.763 B | -57.400 M | 2.190 B | 2.243 B | |
| 31.10% | -103.26% | 3,914.81% | 2.43% | |||
| Net income | 1.345 B | 1.763 B | -57.400 M | 2.190 B | 2.243 B | |
| 31.10% | -103.26% | 3,914.81% | 2.43% |